Related Experiment Video
Updated: Aug 5, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Refining the Genetic Contribution to Type 2 Diabetes Subtypes
Nayra M Al-Thani1,2,3, Salman M Toor1,3, Umm-Kulthum Ismail Umlai1
1College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar.
Diabetes, Obesity & Metabolism
|July 30, 2026
Summary
Genetic analysis reveals distinct subtypes of type 2 diabetes (T2D) in a Middle Eastern population. Findings show varied genetic predispositions and biological pathways across Severe Insulin-Deficient Diabetes (SIDD) and other T2D subtypes.
Area of Science:
- Genetics
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes (T2D) is a heterogeneous metabolic disorder with significant genetic influence.
- Clinical stratification of T2D into subtypes like SIDD, SIRD, MOD, and MARD aids disease management.
- Understanding the genetic basis of these subtypes is crucial for personalized medicine.
Purpose of the Study:
- To investigate the genetic architecture of distinct T2D subtypes within the Qatar Biobank (QBB) cohort.
- To identify genetic loci, polygenic risk scores (PGS), and biological pathways associated with each T2D subtype.
Main Methods:
- Utilized the QBB cohort (n=13,808, with 2687 T2D cases) for comprehensive genetic analysis.
- Assessed polygenic risk scores (PGS) across T2D subtypes using large-scale GWAS data.
- Analyzed SNP associations and identified protein interaction pathways linked to T2D subtypes.
Main Results:
- The Mild Obesity-Related Diabetes (MOD) subtype showed lower polygenic risk scores compared to others.
- Severe Insulin-Deficient Diabetes (SIDD) exhibited more associations with SNPs related to glycemic control.
- Distinct biological pathways were identified for each subtype: glucose homeostasis (SIDD), insulin signaling (SIRD), body fat distribution (MOD), and vascular processes (MARD).
Conclusions:
- Significant heterogeneity in genetic architecture exists across clinically defined T2D subtypes in a Middle Eastern population.
- Findings support differential polygenic burden and subtype-specific genetic associations.
- Subtype-based genetic analyses enhance the biological understanding of T2D heterogeneity.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...